Physicians and facilities
Leading doctors
Director, Peritoneal Cancer Institute
Medical director, Peritoneal Surface Malignancies Program, Centro Medico Teknon
Dr. Sabia is a renowned specialist in surgical oncology, and an expert in the treatment of peritoneal carcinomatosis. He completed his surgical training in Italy in 2008 and joined the Peritoneal Oncology Surgery Unit (UCOP) in Barcelona at the end of 2008, then received training in cytoreductive surgery at the Reina Sofia University Hospital in Cordoba, at the National Cancer Institute in Milan and later at the Washington Cancer Institute with Dr. Paul Sugarbaker.
His areas of interest include advanced abomino-pelvic oncologic surgery both via laparotomy and laparoscopy, HIPEC and PIPAC.
General Surgery Residency
Department of General and Transplant SurgeryHospital Universitario Reina Sofía
Department of General and Emergency SurgerySecond University of Naples
Attending Surgeon ,Peritoneal Surface Malignancies Unit
CSI, Hospital Sant Joan Despi Moisés Broggi, Barcelona
Assistant Surgeon at the Peritoneal Surface Neoplasms Unit Hospital en la Santa Creu i Sant Pau
Training Stay, MedStar Georgetown University Hospital, Washington D.C., USA. Gastrointestinal Neoplasms Center. Peritoneal Surface Malignancy Surgery Program
Senior Attending Surgeon, Peritoneal Surface Malignancies UnitCSI, Hospital Sant Joan Despi Moisés Broggi, Barcelona
Director, Peritoneal Cancer Institute
Teknon Medical Centre, Quironsalud Hospitals Group
Co–director, Peritoneal Cancer Institute
Chief, Peritoneal Surface Malignancies Unit, Consorci Sanitary Integral
Dra. Bijelic is an internationally recognised expert in cytoreductive surgery and peritoneal surface malignancies. She has completed her general surgery residency in Washington DC followed by a subspecialty in surgical oncology and peritoneal surface malignancies. Dra. Bijelic continued as an attending surgical oncologist with Dr Sugarbaker, a pioneer in the field, at the Washington Cancer Institute before founding a peritoneal surface malignancies program at Inova Schar Cancer Institute.
Since 2021, she is the head of the peritoneal surface malignancies unit in Barcelona.
Dra. Bijelic has served on committees dedicated to peritoneal surface malignancies in both American and European leading cancer societies and is the academic coordinator of the European School of Peritoneal Surface Oncology. She is certified by the American Board of Surgery.
Dra. Bijelic is an active clinical researcher who has published numerous articles and lectured internationally.
Attending surgeon
Washington Cancer Institute, Washington DC, USA
Co-lead, Peritoneal Oncology Surgery Unit
Hospital Sant Joan Despi Moisés Broggi, Barcelona
Section Chief , Surgical Oncology
Inova Fairfax Hospital/Inova Schar Cancer Institute
Chief, Peritoneal Oncology Surgery UnitCSI, Hospital Sant Joan Despi Moisés Broggi, Barcelona
Co-director, Peritoneal Cancer Institute
Teknon Medical Centre, Quironsalud Hospitals Group
Clinical Oncologist
Head of the Department of Gastrointestinal Tract Oncology at the Teknon Oncology Institute.
Within Medical Oncology, his area of specialization is the systematic treatment of tumors of the digestive tract (esophagus-gastric, colorectal, pancreatic, bile duct, liver, small intestine, peritoneal and anal canal) and tumors of the endocrine area (thyroid, gastroenteropancreatic neuroendocrine, paragangliomas, pheochromocytomas, adrenal carcinoma, and tumors of other origins of neuroendocrine lineage).
–
Active member and participant in different projects in the European Organisation for Research and Treatment of Cancer (EORTC), the European Society for Medical Oncology (ESMO), the European Neuroendocrine Tumor Society (ENETS), the American Society of Clinical Oncology (ASCO), the Multidisciplinary Spanish Group of Digestive Cancer (GEMCAD) and the Spanish Cooperative Group for Digestive Tumor Therapy (TTD).
Medical Oncologist
Hospital de la Santa Creu i Sant Pau
Clinical oncologist
Institute of Oncology, Hospital Quirónsalud Barcelona
Medical Oncologist
Vall d'Hebron University Hospital
Head of Gastrointestinal and Endocrine Tumor Unit
Teknon Oncology Institute
Facilities
The Peritoneal Cancer Institute operates at the clinical base of the Teknon Medical Centre, one of the largest multidisciplinary hospitals in Spain, which allows the patient to receive any necessary medical care and provide the necessary care and supervision in the postoperative period.
The hospital regularly undergoes international certification and has been certified by Joint Commission International seven times, which guarantees the high quality and safety of medical services.
The hospital employs more than 400 doctors and 2,000 specialists, providing the best medical care for more than 60,000 patients a year.
The versatility of the clinic allows to treat any complications in the postoperative period and comprehensively approach the restoration of the patient’s condition, including the preparation of an individual diet and physiotherapy.
The leading European hospital companies, the German Helios (belonging to Fresenius) and the Spanish Quironsalud have reached an integration agreement that resulted in the creation of the first European operator and one of the most important in the world. The new group will have more than 100,000 employees, will manage 155 health centers, and will maintain both brands, Quirónsalud in Spain and Helios in Germany.
The commitment to top-quality health care, and the commitment to research and patient care as a fundamental axis, have been the hallmarks of both groups and will continue to be those of the new European leader in the sector.
Contact
We are here to help you.
If you would like to request information or resolve any questions about peritoneal cancer and the diagnostic and treatment options, you can contact our team through the form. We will review your message and reply as soon as possible.
Peritoneal Cancer Institute
Teknon Medical Centre
Carrer de Vilana 12, 08022 Barcelona
936 461 163
info@peritonealcancerinstitute.com
©2026 Peritoneal Cancer Institute. All rights reserved.
Peritoneal Cancer Institute® is a registered trademark of DEEP POINT S.L.P.
Unauthorized reproduction, distribution, or use is prohibited.